Replies to post #14004 on Generex Biotechnology Corp. (fka GNBTQ)

[NYD]

Again, read the Conference Call minutes or listen to the Conference Call rather than coming up with your own time line.........Once the IND approval is given, Trial-1 will start hopefully at the beginning of July 2021. It will last approximately 30 days. Trial-1 will determine if we have a "Complete Vaccine" or not. Since the testing has gone great up to date, the team appears very confident going into Trial-1 about whether we have a "Complete Vaccine or not! So, if Trial-1 proves to be successful, we will have the only "Complete Vaccine" on the market, and folks will be lining up world-wide for our vaccine as soon as Trial-1 results are released! As Joe said, we will have a "Homerun" at that time! And yes, if Trial-1 is successful, we will have to go into Trial-2/3 after that. But again, folks will be lining up for GNBT's "Complete Vaccine" once the favorable results of Trial-1 are released! They will not be waiting until after Trial2/3 to do that. Hence, our share price should take a significant move NORTH at that point! So, for those who thought we would have to wait until after Trial-2/3 to see the results of all the testing in our share price, not true! This could be rocking very soon! GLTA!